Testing effectiveness (Phase 2)Study completedNCT02471716
What this trial is testing
Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor
Who this might be right for
Pigmented Villonodular SynovitisTenosynovial Giant Cell Tumor
Five Prime Therapeutics, Inc. 66